nVerses Capital’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12,391
Closed -$113K – 170
2026
Q2
$113K Buy
+12,391
New +$137K 0.17% 238
2024
Q4
– Sell
-1,900
Closed -$29.7K – 602
2024
Q3
$29.7K Sell
1,900
-100
-5% -$1.6K 0.01% 746
2024
Q2
$26.5K Buy
+2,000
New +$27.4K 0.02% 724

Other funds holding OFIX

nVerses Capital's OFIX Position: Q3 2026 in Review

nVerses Capital sold out of Orthofix Medical (OFIX) in Q3 2026, closing a stake of 12,391 shares — an estimated $113K sold.

nVerses Capital first reported a position in OFIX in Q2 2024 and held it in 3 quarters. The position peaked at $113K in Q2 2026. 136 funds tracked by Wall St. Rank hold OFIX as of Q3 2026.

  • nVerses Capital reported no remaining Orthofix Medical position as of Q3 2026 after selling out during the quarter.
  • nVerses Capital sold 12,391 Orthofix Medical shares in Q3 2026, an estimated $113K.
  • nVerses Capital first reported a position in Orthofix Medical in Q2 2024 and held it in 3 quarters.
  • nVerses Capital's Orthofix Medical position peaked at $113K in Q2 2026.
  • 136 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2026.

Based on nVerses Capital's 13F filing for Q3 2026.